Thorne Healthtech (THRN) Stock Price
Thorne Healthtech Price
Over the last 3 years Thorne Healthtech grew revenue by 30.8% annually, reaching 228.71 M USD. For Thorne Healthtech, the net margin of 6.9% is up versus -16.2% a few years ago.
Thorne Healthtech stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Thorne Healthtech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Thorne Healthtech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Thorne Healthtech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Thorne Healthtech Price |
|---|
Thorne Healthtech Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Thorne Healthtech Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e |
|---|---|---|---|---|---|---|
| 102.00 | 138.00 | 185.00 | 228.00 | 287.00 | 374.00 | 430.00 |
| – | 35.29 | 34.06 | 23.24 | 25.88 | 30.31 | 14.97 |
| 43.14 | 46.38 | 52.43 | 50.00 | 50.00 | 50.00 | 50.00 |
| 44.00 | 64.00 | 97.00 | 114.00 | 143.50 | 187.00 | 215.00 |
| -16.00 | – | 9.00 | 5.00 | 23.00 | 48.00 | 67.00 |
| -15.69 | – | 4.86 | 2.19 | 8.01 | 12.83 | 15.58 |
| -16.00 | -2.00 | 10.00 | 15.00 | 16.00 | 33.00 | 57.00 |
| – | -87.50 | -600.00 | 50.00 | 6.67 | 106.25 | 72.73 |
| 8.00 | 51.21 | 58.66 | 52.99 | 52.99 | 52.99 | 52.99 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Thorne Healthtech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Thorne Healthtech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Thorne Healthtech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Thorne Healthtech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Thorne Healthtech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Thorne Healthtech stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Thorne Healthtech Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Thorne Healthtech business model & stock analysis
Thorne Healthtech SWOT Analysis
Strengths
Thorne Healthtech Inc. possesses strong brand recognition and reputation in the healthtech industry. The company has a diverse portfolio of innovative products and services, contributing to its market leadership. Thorne also has a highly skilled and experienced workforce, enabling them to develop high-quality and cutting-edge solutions. Additionally, the company benefits from strong financial stability and strategic partnerships, enhancing its competitive advantage.
Weaknesses
One of Thorne Healthtech Inc.'s weaknesses is its limited geographical presence, primarily focusing on specific regions or markets. This can hinder the company's growth potential and market expansion opportunities. Another weakness is its reliance on third-party suppliers for raw materials and components, which could lead to potential supply chain disruptions or quality control issues.
Opportunities
The healthtech industry is experiencing significant growth worldwide, providing Thorne Healthtech Inc. with ample opportunities for market expansion. By leveraging their expertise and reputation, Thorne can further penetrate emerging markets and capitalize on the rising demand for innovative healthcare solutions. The increasing adoption of digital health technologies and telemedicine also opens doors for Thorne to develop and offer new tech-based solutions.
Threats
Thorne Healthtech Inc. faces intense competition from existing players and new entrants in the healthtech sector. This may lead to price wars, margin erosion, or loss of market share if not adequately addressed. Regulatory changes and evolving legal frameworks for healthcare products and services can also present challenges for the company, requiring continuous adaptation and compliance efforts. Additionally, economic uncertainties and fluctuations in exchange rates could impact Thorne's financial performance and international operations.
Thorne Healthtech Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Thorne Healthtech Segments
Thorne Healthtech Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Thorne Healthtech historical P/E ratio, EBIT multiple, and P/S ratio
Thorne Healthtech annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Thorne Healthtech's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Thorne Healthtech's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Thorne Healthtech's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Thorne Healthtech shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Thorne Healthtech Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 10/11/2023 | Downgrade | OutperformNeutral | 62 | |
| 10/10/2023 | Downgrade | OutperformNeutral | 62 | |
| 8/30/2023 | Downgrade | OutperformMarket Perform | 58 | |
| 8/29/2023 | Downgrade | OutperformMarket Perform | 58 | |
| 8/11/2023 | Maintained | Buy | 63 | |
| 8/10/2023 | Maintained | Buy | 63 | |
| 4/4/2023 | Maintained | Buy | 63 | |
| 4/3/2023 | Maintained | Buy | 63 | |
| 11/17/2022 | Maintained | Buy | 63 | |
| 11/11/2022 | Maintained | Outperform | 48 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Thorne Healthtech Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 11/8/2023 | 0.05USD | 0.07USD | 75.57 MUSD | - | 2023 Q3 |
| 8/8/2023 | 0.07USD | 0.15USD | 68.46 MUSD | - | 2023 Q2 |
| 5/11/2023 | 0.06USD | 0.06USD | 68.46 MUSD | - | 2023 Q1 |
| 11/9/2022 | 0.16USD | 0.12USD | 63.91 MUSD | - | 2022 Q3 |
| 8/9/2022 | -0.00USD | -0.05USD | -USD | - | 2022 Q2 |
| 5/11/2022 | 0.10USD | 0.09USD | 56.12 MUSD | - | 2022 Q1 |
| 3/14/2022 | 0.03USD | 0.06USD | 49.08 MUSD | - | 2021 Q4 |
| 11/10/2021 | 0.00USD | 0.01USD | 108.02 MUSD | - | 2021 Q3 |
Thorne Healthtech shareholder structure
| % | Name |
|---|---|
0.30432% | |
0.18897% | |
0.18875% | |
0.11359% | |
0.00676% | |
0.00569% |
Thorne Healthtech Executives and Management Board
7 members · avg. age 56 · 29 % women
Mr. Paul Jacobson (69)
Chairman of the Board, Chief Executive Officer, Co-Founder · since 2023
4.09 M USD
Management
Mr. Thomas Mckenna (63)
Chief Operating Officer, Director · since 2010
Mr. William Mccamy (54)
President
Ms. Saloni Varma (43)
Chief Financial Officer, Director · since 2021
Board of Directors
Ms. Sarah Kauss (47)
Independent Director
Mr. Riccardo Braglia (63)
Independent Director
Mr. Toshitaka Inuzuka (54)
Independent Director
Thorne Healthtech Supply Chain
Thorne Healthtech Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.21 | — | — | ||
| 2 | 0.02 | — | — | ||
| 3 | 0.18 | — | — | ||
| 4 | -0.25 | — | — | ||
| 5 | -0.45 | — | — |
Frequently asked questions about Thorne Healthtech
Thorne Healthtech Inc operates under a business model focused on improving health and wellness through the development and distribution of high-quality nutritional supplements and personalized health solutions. The company aims to provide scientifically-backed products that support various aspects of health, including immune function, stress management, athletic performance, and more. Thorne Healthtech Inc prioritizes research and innovation to create safe and effective products that meet the ever-evolving health needs of individuals. By leveraging their expertise in nutritional science, Thorne Healthtech Inc strives to empower individuals to take control of their health and enhance their overall well-being.
Thorne Healthtech Inc is primarily active in the healthcare and technology industries.
The main competitors of Thorne Healthtech Inc in the market are leading healthcare companies such as Johnson & Johnson, Pfizer, and Roche. These established companies have a strong presence and offer similar products and services in the healthcare industry. Thorne Healthtech Inc competes by differentiating itself through innovative and high-quality health products, holistic approaches, and a focus on natural remedies. With its unique offerings and customer-centric approach, Thorne Healthtech Inc aims to carve a niche for itself in the competitive market landscape.
Thorne Healthtech Inc., a renowned company in the healthcare industry, has an impressive history and background. Founded in [insert year], Thorne Healthtech Inc. has been providing innovative solutions and high-quality products to improve people's well-being. With a strong focus on research and development, the company has become a leader in the market, offering a wide range of healthcare products and services. Thorne Healthtech Inc. has continuously evolved over the years, expanding its reach both nationally and internationally. Known for its commitment to excellence, Thorne Healthtech Inc. remains dedicated to enhancing the health and vitality of individuals worldwide.
Thorne Healthtech Inc has achieved several significant milestones in their journey. They have successfully expanded their product offerings, gained a strong customer base, and established themselves as a leading player in the healthcare technology industry. Thorne Healthtech Inc has also made notable advancements in research and development, resulting in innovative solutions and cutting-edge technologies. Through strategic partnerships and acquisitions, the company has further solidified its market position and global presence. Thorne Healthtech Inc continues to deliver exceptional products and services, shaping the future of healthcare technology with their unwavering commitment to excellence and innovation.
Thorne Healthtech Inc is primarily present in the United States, Canada, Europe, and Asia. With a strong global presence, the company has established a significant market share in these regions. Thorne Healthtech Inc's dedication to expanding its reach beyond borders has allowed it to tap into diverse customer bases and explore new growth opportunities. With a focus on delivering innovative health technology solutions, Thorne Healthtech Inc continues to make its mark in healthcare markets worldwide.
Thorne Healthtech Inc represents values of innovation, quality, and excellence in the field of health technology. The company's corporate philosophy revolves around improving the well-being of individuals through cutting-edge solutions and nutritional support. Thorne Healthtech Inc prioritizes research and development, ensuring that their products are backed by rigorous scientific evidence. With a strong commitment to providing safe and effective health products, Thorne Healthtech Inc has gained a reputable position in the industry. Their dedication to high standards and customer satisfaction drives their mission of enhancing lives through advanced health technologies.
10 analysts currently rate the Thorne Healthtech stock: 7 recommend buying, 3 holding and 0 selling.
The Thorne Healthtech share (THRN) is listed on 3 stock exchanges, including: NASDAQ (THRN), Frankfurt (F7G.F), Düsseldorf (F7G.DU).
Thorne Healthtech Inc is a company specialized in the development and marketing of high-quality dietary supplements. The company is based in the USA and has been operating in the industry for over 30 years. With a focus on scientifically backed products and a dedicated team of experts, Thorne Healthtech Inc has developed a business model that focuses on offering high-quality products tailored to the needs of athletes, medical professionals, and consumers. The company has various divisions that cater to the needs of different target groups. The first division is sports nutrition, offering a wide range of products designed for athletes of all performance levels. These range from protein powders and carbohydrate supplements to products tailored to the needs of athletes before, during, and after training. Another important division of the company is medical nutrition, offering products tailored to the needs of patients suffering from conditions such as diabetes, liver disease, or gastrointestinal problems. These products have been developed to alleviate the symptoms of the conditions and improve the health of patients. Another division is animal nutrition. Thorne Healthtech Inc has developed a wide range of products tailored to the needs of dogs and cats. These products include supplements that support digestion and joint health, as well as products aimed at improving the well-being of animals. Another important area of Thorne Healthtech Inc is women's and men's health, offering products tailored to the needs of women and men, such as dietary supplements that help balance hormones or enhance libido. The company also offers a wide range of products focused on general health and well-being. These include products like multivitamin supplements that complement daily nutrition and are tailored to the needs of people of all ages. The business model of Thorne Healthtech Inc is based on scientifically backed products developed by a dedicated team of experts. The company collaborates with leading research institutions and medical professionals to ensure that its products meet the highest quality standards. Furthermore, the company only uses the best available ingredients and ensures that all products are manufactured in facilities that meet the highest quality standards. The company distributes its products both online and through a network of distribution partners and medical professionals. This allows Thorne Healthtech Inc to reach a wide range of customers, including athletes, medical professionals, and consumers in search of high-quality dietary supplements. Overall, the business model of Thorne Healthtech Inc aims to offer high-quality products tailored to the needs of different target groups. With a strong focus on research and development, the company has developed a wide range of products that cater to the needs of athletes, medical professionals, and consumers.
The revenue cannot currently be calculated for Thorne Healthtech.
The profit cannot currently be calculated for Thorne Healthtech.
The P/E ratio cannot be calculated for Thorne Healthtech at the moment.
The P/S cannot be calculated for Thorne Healthtech currently.
The Eulerpool Quality Score for Thorne Healthtech is 4/10.
The ISIN of Thorne Healthtech is US8852601090. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Thorne Healthtech is THRN. The ticker symbol is used to trade Thorne Healthtech shares on the stock exchange.
Thorne Healthtech is assigned to the 'Non-cyclical consumption' sector.
The dividends of Thorne Healthtech are distributed in USD.
Thorne Healthtech stock
Thorne Healthtech Peer Group
Thorne Healthtech Ticker
Thorne Healthtech FIGI
All fundamentals and in-depth analysis of Thorne Healthtech
Our stock analysis for Thorne Healthtech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Thorne Healthtech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.